NasdaqCM - Nasdaq Real Time Price USD

Entera Bio Ltd. (ENTX)

2.1500
-0.0700
(-3.15%)
At close: May 9 at 4:00:00 PM EDT
2.1500
+0.04
+(1.90%)
After hours: May 9 at 4:05:08 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
181
181
0
134
571
Cost of Revenue
172
172
0
101
373
Gross Profit
9
9
0
33
198
Operating Expense
9,594
9,594
8,891
13,050
12,415
Operating Income
-9,585
-9,585
-8,891
-13,017
-12,217
Net Non Operating Interest Income Expense
58
58
31
83
-29
Pretax Income
-9,527
-9,527
-8,860
-12,934
-12,246
Tax Provision
14
14
29
137
-59
Net Income Common Stockholders
-9,541
-9,541
-8,889
-13,071
-12,187
Diluted NI Available to Com Stockholders
-9,541
-9,541
-8,889
-13,071
-12,187
Basic EPS
-0.26
-0.25
-0.31
-0.45
-0.47
Diluted EPS
-0.26
-0.25
-0.31
-0.45
-0.47
Basic Average Shares
35,271.3110
37,650.1790
29,007.7940
28,808.0900
26,133.7700
Diluted Average Shares
35,271.3110
37,650.1790
29,007.7940
28,808.0900
26,133.7700
Total Operating Income as Reported
-9,585
-9,585
-8,891
-13,017
-12,217
Total Expenses
9,766
9,766
8,891
13,151
12,788
Net Income from Continuing & Discontinued Operation
-9,541
-9,541
-8,889
-13,071
-12,187
Normalized Income
-9,541
-9,541
-8,889
-13,071
-12,187
Interest Expense
--
--
--
--
29
Net Interest Income
58
58
31
83
-29
EBIT
-9,585
-9,585
-8,891
-13,017
-12,217
EBITDA
-9,539
-9,539
-8,835
-12,953
-12,164
Reconciled Cost of Revenue
172
172
0
101
373
Reconciled Depreciation
46
46
56
64
53
Net Income from Continuing Operation Net Minority Interest
-9,541
-9,541
-8,889
-13,071
-12,187
Normalized EBITDA
-9,539
-9,539
-8,835
-12,953
-12,164
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 6/28/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ELTX Elicio Therapeutics, Inc.
5.49
-1.44%
 
XTLB XTL Biopharmaceuticals Ltd.
1.2600
+1.61%
 
THAR Tharimmune, Inc.
1.5100
+1.34%
 
ATXI Avenue Therapeutics, Inc.
0.2400
+9.04%
 
RZLT Rezolute, Inc.
3.7000
-0.54%
 
ERNA Ernexa Therapeutics Inc.
0.1996
-0.15%
 
OVID Ovid Therapeutics Inc.
0.2901
-1.33%
 
RPTX Repare Therapeutics Inc.
1.3600
0.00%
 
PYPD PolyPid Ltd.
2.7700
-0.72%
 
TSBX Turnstone Biologics Corp.
0.3399
+2.13%